Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350532 · ClinicalTrials.gov registry record · Phase 2
Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT00350532 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 43 participants.
The verdict
NCT00350532, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the amount of acetylcholine release after a single injection of clonidine in normal volunteers and individuals with neuropathic pain.
Interventions
- DRUG clonidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350532
The ClinicalTrials.gov registry entry for NCT00350532 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which clonidine is the first listed.
NCT00350532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00350532 about?
NCT00350532 is a clinical study titled "Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain". The purpose of this study is to compare the amount of acetylcholine release after a single injection of clonidine in normal volunteers and individuals with neuropathic pain.
What is the current status of trial NCT00350532?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2004-09. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00350532?
The interventions under investigation include: clonidine (DRUG).
Who is sponsoring clinical trial NCT00350532?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.